EP2729008 - SYSTEMS, METHODS, AND FORMULATIONS FOR TREATING CANCER [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.02.2018 Database last updated on 30.07.2024 | |
Former | The patent has been granted Status updated on 03.03.2017 | ||
Former | Grant of patent is intended Status updated on 25.02.2017 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states Research Cancer Institute of America 1680 E. Herndon Ave. 102 Fresno, California 93720 / US | [2014/20] | Inventor(s) | 01 /
NEZAMI, MD, Mohammad 10474 E. Fieldstone Ave. Clovis, California 93649 / US | [2014/20] | Representative(s) | Zacco Sweden AB P.O. Box 5581 Löjtnantsgatan 21 114 85 Stockholm / SE | [N/P] |
Former [2017/14] | Zacco Sweden AB P.O. Box 5581 114 85 Stockholm / SE | ||
Former [2014/45] | Zacco Sweden AB Valhallavägen 117 P.O. Box 5581 114 85 Stockholm / SE | ||
Former [2014/20] | Danielsson, Maria Helena Zacco Sweden AB P.O. Box 114 114 85 Stockholm / SE | Application number, filing date | 12806902.8 | 06.07.2012 | [2017/14] | WO2012US45821 | Priority number, date | US201161505393P | 07.07.2011 Original published format: US 201161505393 P | US201161507950P | 14.07.2011 Original published format: US 201161507950 P | [2014/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013006821 | Date: | 10.01.2013 | Language: | EN | [2013/02] | Type: | A1 Application with search report | No.: | EP2729008 | Date: | 14.05.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.01.2013 takes the place of the publication of the European patent application. | [2014/20] | Type: | B1 Patent specification | No.: | EP2729008 | Date: | 05.04.2017 | Language: | EN | [2017/14] | Search report(s) | International search report - published on: | US | 10.01.2013 | (Supplementary) European search report - dispatched on: | EP | 30.09.2014 | Classification | IPC: | A61K31/192, A61K31/352, A61K31/353, A61K36/82, A61P35/00 | [2014/44] | CPC: |
A61K31/352 (EP,KR,RU,US);
A61K31/192 (EP,KR,RU,US);
A61K31/375 (KR);
A61K31/385 (EP,KR,US);
A61K33/00 (EP,US);
A61K33/24 (EP,RU,US);
A61K33/40 (EP,KR,US);
A61K36/82 (EP,KR,US);
A61K45/06 (EP,KR,US);
A61K47/02 (KR,US);
A61K9/0019 (KR,US);
A61P35/00 (EP,KR,US);
A61K9/08 (RU)
(-)
| C-Set: |
A61K31/192, A61K2300/00 (US,EP);
A61K31/352, A61K2300/00 (EP,US);
A61K31/385, A61K2300/00 (US,EP);
A61K33/24, A61K2300/00 (EP); |
Former IPC [2014/20] | A01N43/54, A01N37/00, A61K31/19 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/20] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | SYSTEME, VERFAHREN UND FORMULIERUNGEN ZUR BEHANDLUNG VON KREBS | [2014/20] | English: | SYSTEMS, METHODS, AND FORMULATIONS FOR TREATING CANCER | [2014/20] | French: | SYSTÈMES, MÉTHODES, ET FORMULATIONS POUR TRAITER LE CANCER | [2014/20] | Entry into regional phase | 03.02.2014 | National basic fee paid | 03.02.2014 | Search fee paid | 03.02.2014 | Designation fee(s) paid | 03.02.2014 | Examination fee paid | Examination procedure | 03.02.2014 | Examination requested [2014/20] | 17.04.2015 | Amendment by applicant (claims and/or description) | 09.03.2016 | Despatch of a communication from the examining division (Time limit: M04) | 07.07.2016 | Reply to a communication from the examining division | 27.10.2016 | Communication of intention to grant the patent | 24.02.2017 | Fee for grant paid | 24.02.2017 | Fee for publishing/printing paid | 24.02.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | EP17163492.6 / EP3326625 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 09.03.2016 | Opposition(s) | 08.01.2018 | No opposition filed within time limit [2018/11] | Fees paid | Renewal fee | 14.07.2014 | Renewal fee patent year 03 | 10.07.2015 | Renewal fee patent year 04 | 11.07.2016 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 06.07.2012 | AL | 05.04.2017 | AT | 05.04.2017 | CY | 05.04.2017 | CZ | 05.04.2017 | DK | 05.04.2017 | EE | 05.04.2017 | FI | 05.04.2017 | HR | 05.04.2017 | LT | 05.04.2017 | LV | 05.04.2017 | MC | 05.04.2017 | MK | 05.04.2017 | PT | 05.04.2017 | RO | 05.04.2017 | RS | 05.04.2017 | SE | 05.04.2017 | SI | 05.04.2017 | SK | 05.04.2017 | SM | 05.04.2017 | BG | 05.07.2017 | NO | 05.07.2017 | GR | 06.07.2017 | LU | 06.07.2017 | MT | 06.07.2017 | BE | 31.07.2017 | IS | 05.08.2017 | [2020/34] |
Former [2020/28] | HU | 06.07.2012 | |
AT | 05.04.2017 | ||
CY | 05.04.2017 | ||
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
MC | 05.04.2017 | ||
MK | 05.04.2017 | ||
PT | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
MT | 06.07.2017 | ||
BE | 31.07.2017 | ||
IS | 05.08.2017 | ||
Former [2019/51] | HU | 06.07.2012 | |
AT | 05.04.2017 | ||
CY | 05.04.2017 | ||
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
MC | 05.04.2017 | ||
MK | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
MT | 06.07.2017 | ||
BE | 31.07.2017 | ||
IS | 05.08.2017 | ||
Former [2019/46] | HU | 06.07.2012 | |
AT | 05.04.2017 | ||
CY | 05.04.2017 | ||
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
MC | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
MT | 06.07.2017 | ||
BE | 31.07.2017 | ||
IS | 05.08.2017 | ||
Former [2019/31] | HU | 06.07.2012 | |
AT | 05.04.2017 | ||
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
MC | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
MT | 06.07.2017 | ||
BE | 31.07.2017 | ||
IS | 05.08.2017 | ||
Former [2019/30] | AT | 05.04.2017 | |
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
MC | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
MT | 06.07.2017 | ||
BE | 31.07.2017 | ||
IS | 05.08.2017 | ||
Former [2018/43] | AT | 05.04.2017 | |
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
MT | 06.07.2017 | ||
BE | 31.07.2017 | ||
IS | 05.08.2017 | ||
Former [2018/39] | AT | 05.04.2017 | |
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
BE | 31.07.2017 | ||
IS | 05.08.2017 | ||
Former [2018/34] | AT | 05.04.2017 | |
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
LU | 06.07.2017 | ||
IS | 05.08.2017 | ||
Former [2018/25] | AT | 05.04.2017 | |
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SI | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
IS | 05.08.2017 | ||
Former [2018/11] | AT | 05.04.2017 | |
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SK | 05.04.2017 | ||
SM | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
IS | 05.08.2017 | ||
Former [2018/10] | AT | 05.04.2017 | |
CZ | 05.04.2017 | ||
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RO | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
SK | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
IS | 05.08.2017 | ||
Former [2018/09] | AT | 05.04.2017 | |
DK | 05.04.2017 | ||
EE | 05.04.2017 | ||
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
IS | 05.08.2017 | ||
Former [2017/50] | AT | 05.04.2017 | |
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
LV | 05.04.2017 | ||
RS | 05.04.2017 | ||
SE | 05.04.2017 | ||
BG | 05.07.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
IS | 05.08.2017 | ||
Former [2017/49] | AT | 05.04.2017 | |
FI | 05.04.2017 | ||
HR | 05.04.2017 | ||
LT | 05.04.2017 | ||
NO | 05.07.2017 | ||
GR | 06.07.2017 | ||
IS | 05.08.2017 | Documents cited: | Search | [Y]WO2005023179 (ATON PHARMA INC [US], et al); | [Y]US2010316733 (LOCKLEAR KENNETH R [US]); | International search | [Y]US6299925 (XIONG WEIHONG [US], et al); | [Y]US2011104100 (RIORDAN NEIL H [US], et al); | [Y]US2011118309 (ATADJA PETER WISDOM [US]); |